APA (7th ed.) Citation

AK, W., AB, R., M, T., D, M., S, S., KL, C., . . . SJ, D. (2024). A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2023.12.06.570390

Chicago Style (17th ed.) Citation

AK, Weiner, et al. "A Proteogenomic Surfaceome Study Identifies DLK1 as an Immunotherapeutic Target in Neuroblastoma." BioRxiv : The Preprint Server for Biology 2024. https://doi.org/10.1101/2023.12.06.570390.

MLA (9th ed.) Citation

AK, Weiner, et al. "A Proteogenomic Surfaceome Study Identifies DLK1 as an Immunotherapeutic Target in Neuroblastoma." BioRxiv : The Preprint Server for Biology, 2024, https://doi.org/10.1101/2023.12.06.570390.